MONTREAL, Feb. 17, 2022 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX Venture: IBT) is pleased to announce that all six nominees listed in its management proxy circular dated January 4, 2022 were re-elected as directors at the Company's annual and special meeting held today in Montreal.
At the meeting, shareholders also approved a resolution ratifying, confirming and approving the "reload" of 527,008 common shares under IBEX's Incentive Stock Option Plan and a resolution confirming an amendment to IBEX's general by-laws so as to provide for meetings of the shareholders, and voting thereat, by telephonic, electronic or other communication facility. Both resolutions were adopted by a vote of more than 99% of the votes cast at the meeting.
At the meeting, shareholders also reappointed PricewaterhouseCoopers LLP, Chartered Professional Accountants, as IBEX's auditor.
ABOUT IBEX
IBEX manufactures and markets enzymes for biomedical use through its wholly owned subsidiary IBEX Pharmaceuticals Inc. (Montréal, QC). IBEX Pharmaceuticals also manufactures and markets a series of arthritis assays, which are widely used in osteoarthritis research.
For more information, please visit the Company's website at www.ibex.ca.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
Paul Baehr President & CEO IBEX Technologies Inc. 514-344-4004 x 143
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), and NovaScan, Inc., a company that develops breakthrough technology for cancer detection and stratification, announce that they have...
The United States of America and ReNew Health Group LLC have settled a nursing home whistleblower claim involving allegations that the nursing home chain submitted false Medicare claims.
We need transparency and accountability in our nursing homes....
The 5p- Society of North America, along with families and support organizations from over 95 countries, are bringing awareness of 5p Deletion Syndrome also known as 5p Minus (5p-)...
Alleva, a leading provider of electronic medical record (EMR) solutions, attended the first-ever East Coast TCIV conference last week in Palm Beach, Florida. The company's CEO, Steve McCall, Director of Sales, John David, and Manager of Strategic...
The Canadian Food Inspection Agency (CFIA) has confirmed the presence of emerald ash borer (EAB - Agrilus planipennis) in the City of Vancouver, British Columbia. These detections, which are outside of currently regulated areas for emerald ash borer...